Differential effects of (3,4-dihydroxyphenylamino)-2-imidazoline (DPI) on hyperactivity responses to dopamine agonists injected in the nucleus accumbens.
D000818:Animals; D002395:Catecholamines / Q000494:pharmacology*; D003913:Dextroamphetamine / Q000494:pharmacology; D004298:Dopamine / Q000494:pharmacology / Q000502:physiology*; D004347:Drug Interactions; D004874:Ergonovine / Q000494:pharmacology; D007093:Imidazoles / Q000494:pharmacology*; D007267:Injections; D009043:Motor Activity / Q000187:drug effects*; D009714:Nucleus Accumbens; D051381:Rats; D013764:Tetrahydronaphthalenes / Q000494:pharmacology
D002395:Catecholamines; D007093:Imidazoles; D013764:Tetrahydronaphthalenes; D003913:Dextroamphetamine; D004298:Dopamine; D004874:Ergonovine